Ak. Chakrabarti et al., IMMUNOLOCALIZATION OF CYTOPLASMIC AND MYELIN MCALPAIN IN TRANSFECTED SCHWANN-CELLS .2. EFFECT OF WITHDRAWAL OF GROWTH-FACTORS, Journal of neuroscience research, 47(6), 1997, pp. 609-616
We have examined the reversal of the regulatory effect of growth facto
rs on calpain/calpastatin activity in transfected Schwann cells (tSc)
after their subsequent withdrawal, Removal of nerve growth factor (NGF
) or cyclic adenosine monophosphate (cAMP) from tSc resulted in a smal
ler loss of mu calpain (37%) and mcalpain (36.5%) activity compared to
treated cells from which the growth factors were not withdrawn, The m
u calpain activity increased approximately 12% following withdrawal of
acidic fibroblast growth factor (aFGF) and basic fibroblast growth fa
ctor (bFGF) at 24 hr, while the increased mcalpain activity was more t
han 30-40% compared with that of cells that were continuously treated,
The activity of both isoforms returned to their normal levels (untrea
ted) at 48-72 hr following withdrawal of various growth factors, inclu
ding NGF, cAMP, aFGF, bFGF, platelet-derived growth factor aa (PDGFaa)
, and PDGFbb. The inhibitory activity of calpastatin was greater than
control following withdrawal of NGF, cAMP, PDGFaa, or PDGFbb at 24 hr
and this inhibitory activity was less with treatment by aFGF and bFGF,
The control activity was restored at 48 hr following withdrawal of th
ese factors, The intensity of the cytoplasmic calpain immunoreactivity
was significantly decreased in the nuclear and nonnuclear regions of
the cytoplasm, respectively, following withdrawal of cAMP at 144 hr. R
emoval of bFGF from the medium resulted in an increase of cytoplasmic
calpain immunoreactivity in the nuclear regions and cytoplasm, while t
here was dramatic loss of myelin calpain immunoreactivity from both th
e nuclear region and cytoplasm, The changes in calpain activity and im
munoreactivity in tSc following withdrawal of growth factors suggest t
hat release of calpain from membrane to cytosol may be regulated by th
ese factors. (C) 1997 Wiley-Liss, Inc.